Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 3 Rectal Neoplasms 2 Neoplasms 2 Glioma 2 Glioblastoma 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sinonasal Squamous Cell Carcinoma 1 Sarcoma 1 Radiation Injuries 1 Prostatic Neoplasms 1 Postoperative Complications 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Melanoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Low Anterior Resection Syndrome 1 Liposarcoma 1 Leiomyosarcoma 1 Hepatic Veno-Occlusive Disease 1 Head and Neck Neoplasms 1 Fatigue 1

Interventions

Cisplatin 13 Magnetic Resonance Spectroscopy 9 Specimen Handling 8 Radiotherapy 7 Platinum 7 1,2-diaminocyclohexaneplatinum II citrate 7 Radiotherapy, Intensity-Modulated 4 Radiation 4 Biopsy 4 Surveys and Questionnaires 3 Nivolumab 3 Carboplatin 3 pembrolizumab 2 durvalumab 2 Observation 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 Docetaxel 2 Disulfides 2 Chemoradiotherapy 2 Cetuximab 2 (225)Ac-DOTA-c(RGDyK) 2 niraparib 1 merphos 1 ipatasertib 1 dostarlimab 1 cemiplimab 1 cabozantinib 1 balstilimab 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Oropharyngeal Neoplasms × Surgical Procedures, Operative × 30 days × Clear all

NCT06702033 2026-05-15

MINT-2

Washington University School of Medicine

Phase 2 Recruiting

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡